What This Synaptics Filing Signals Long-Term Investors
A recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesA recent CFO Form 4 shows a small share disposition at Synaptics while the company reports 10% revenue growth. This a...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A fresh AI-led analysis identifies a growing Qualified Buyer Gap in new-home markets, driven by slower job growth in ...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
The State of the Union delivered broad economic themes, but housing policy specifics were scarce, prompting questions...
Bilt Rewards rolls out an AI-powered Neighborhood Concierge, enabling renters to pay rent, book amenities, and tap in...
A coalition of Senate Democrats is pressing Florida Attorney General Pam Bondi to launch a formal probe into Binance ...
Insider moves during earnings season can spark questions about a company’s future. This article dives into what it me...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...
Vitalik Buterin reveals an ambitious plan to build 'sanctuary technologies' within Ethereum, aiming to shield people ...
Liquidity squeezes in major private credit funds put the trillion private credit boom under stress. Bitcoin could be ...
Shark Tank’s Kevin O’Leary argues that the ability to execute trumps workplace location as firms accelerate return-to...